Triple

T16952549
Position Surface form Disambiguated ID Type / Status
Subject Ambien E411218 entity
Predicate actsOn P9769 FINISHED
Object GABA-A receptor
The GABA-A receptor is a ligand-gated chloride ion channel in the central nervous system that mediates fast inhibitory neurotransmission and is a primary target of many sedative, anxiolytic, and hypnotic drugs.
E1243368 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: GABA-A receptor | Statement: [Ambien, actsOn, GABA-A receptor]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: GABA-A receptor
Context triple: [Ambien, actsOn, GABA-A receptor]
  • A. GABA
    GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the mammalian central nervous system, crucial for reducing neuronal excitability and regulating muscle tone and anxiety.
  • B. NMDA receptor
    The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
  • C. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • D. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • E. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: GABA-A receptor
Triple: [Ambien, actsOn, GABA-A receptor]
Generated description
The GABA-A receptor is a ligand-gated chloride ion channel in the central nervous system that mediates fast inhibitory neurotransmission and is a primary target of many sedative, anxiolytic, and hypnotic drugs.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: GABA-A receptor
Target entity description: The GABA-A receptor is a ligand-gated chloride ion channel in the central nervous system that mediates fast inhibitory neurotransmission and is a primary target of many sedative, anxiolytic, and hypnotic drugs.
  • A. GABA
    GABA (gamma-aminobutyric acid) is the primary inhibitory neurotransmitter in the mammalian central nervous system, crucial for reducing neuronal excitability and regulating muscle tone and anxiety.
  • B. NMDA receptor
    The NMDA receptor is a glutamate-activated ion channel in the brain that plays a key role in synaptic plasticity, learning, and memory, and is implicated in various neurological and psychiatric disorders.
  • C. M2 muscarinic acetylcholine receptor
    The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
  • D. CB1 receptor
    The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
  • E. CB2 receptor
    The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d886c9c9d481909afe222093641cae completed April 10, 2026, 5:12 a.m.
NER Named-entity recognition batch_69e3d0197f308190af7185fc9cc7a6e9 completed April 18, 2026, 6:40 p.m.
NED1 Entity disambiguation (via context triple) batch_6a00d46213b08190b33b48d12bc795d1 completed May 10, 2026, 6:54 p.m.
NEDg Description generation batch_6a00d5503be88190ac15a327ff3782ec completed May 10, 2026, 6:58 p.m.
NED2 Entity disambiguation (via description) batch_6a00d66e450c8190ae0befd3d7875ed8 completed May 10, 2026, 7:03 p.m.
Created at: April 10, 2026, 5:31 a.m.